Krystal Biotech (KRYS) Change in Acquisitions & Divestments (2021 - 2026)
Krystal Biotech (KRYS) has disclosed Change in Acquisitions & Divestments for 5 consecutive years, with $85.8 million as the latest value for Q4 2025.
- Quarterly Change in Acquisitions & Divestments rose 41.77% to $85.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $375.6 million through Dec 2025, up 25.83% year-over-year, with the annual reading at $375.6 million for FY2025, 25.83% up from the prior year.
- Change in Acquisitions & Divestments hit $85.8 million in Q4 2025 for Krystal Biotech, down from $95.8 million in the prior quarter.
- In the past five years, Change in Acquisitions & Divestments ranged from a high of $161.2 million in Q2 2023 to a low of $1.2 million in Q2 2021.
- Historically, Change in Acquisitions & Divestments has averaged $73.4 million across 5 years, with a median of $76.9 million in 2023.
- Biggest five-year swings in Change in Acquisitions & Divestments: soared 4992.62% in 2022 and later crashed 58.83% in 2024.
- Year by year, Change in Acquisitions & Divestments stood at $21.0 million in 2021, then soared by 395.73% to $104.1 million in 2022, then fell by 28.33% to $74.6 million in 2023, then decreased by 18.9% to $60.5 million in 2024, then skyrocketed by 41.77% to $85.8 million in 2025.
- Business Quant data shows Change in Acquisitions & Divestments for KRYS at $85.8 million in Q4 2025, $95.8 million in Q3 2025, and $105.3 million in Q2 2025.